View Older Stories View More Recent Stories

Mar 13, 2026 09:08AM William Blair Reiterates Outperform Rating on ServiceTitan (TTAN): 'we view valuation as attractive'
Mar 13, 2026 08:06AM William Blair Reiterates Market Perform Rating on El Pollo Loco (LOCO) following earnings report
Mar 13, 2026 08:00AM Oxford Lane Capital Corp. Prices Preferred Stock Offering
Mar 13, 2026 07:00AM Leading broker sees 'an attractive risk/reward' in this major AI chip stock
Mar 13, 2026 04:32AM William Blair Downgrades PagerDuty (PD) to Market Perform
Mar 12, 2026 05:04PM William Blair Reiterates Outperform Rating on VSE Corporation (VSEC): "We view today’s 7% stock drawdown as a buying opportunity"
Mar 12, 2026 04:29PM Form N-CEN WILLIAM BLAIR FUNDS For: Dec 31
Mar 12, 2026 04:01PM Xenon Pharmaceuticals closes $747.5 million public offering
Mar 12, 2026 04:01PM Dianthus Therapeutics completes $719 million public offering
Mar 12, 2026 04:01PM Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Mar 12, 2026 04:01PM Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 12, 2026 10:35AM William Blair Reiterates Outperform Rating on Tenaya Therapeutics Inc (TNYA): "entering 2026 with increasing momentum"
Mar 12, 2026 09:17AM William Blair Reiterates Market Perform Rating on UiPath Inc. (PATH): "incrementally encouraged"
Mar 12, 2026 08:45AM William Blair Reiterates Outperform Rating on Aveanna Healthcare Holdings Inc (AVAH) following acquisition announcement
Mar 12, 2026 08:31AM Oxford Lane Capital announces preferred stock offering
Mar 12, 2026 08:30AM Oxford Lane Capital Corp. Announces Preferred Stock Offering
Mar 12, 2026 06:02AM William Blair: 'We like CRCL for long-term investors'
Mar 11, 2026 04:41PM William Blair Reiterates Outperform Rating on AppLovin Corp (APP) following meeting with management
Mar 11, 2026 04:11PM William Blair Reiterates Market Perform Rating on Sprinklr Inc (CXM): "a lot to prove on the execution front"
Mar 11, 2026 05:43AM William Blair: 'increasing likelihood that Oracle sees significant earnings growth acceleration over the coming years'
Mar 10, 2026 10:54PM Dianthus Therapeutics prices $625 million public stock offering
Mar 10, 2026 10:54PM Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
Mar 10, 2026 10:39PM Xenon Pharmaceuticals prices $650 million stock offering at $57 per share
Mar 10, 2026 10:39PM Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
Mar 10, 2026 02:34PM William Blair Reiterates Outperform Rating on Veeva Systems (VEEV) amid Ostro acquisition
Mar 10, 2026 02:25PM William Blair Reiterates Outperform Rating on Tenax Therapeutics (TENX): "continue to believe positive top-line results from LEVEL have the potential to drive multifold upside"
Mar 10, 2026 02:00PM Medline completes $3.5 billion secondary stock offering
Mar 10, 2026 02:00PM Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
Mar 10, 2026 12:19PM William Blair Reiterates Outperform Rating on Exagen (XGN) following Q4 results
Mar 10, 2026 09:29AM William Blair Reiterates Outperform Rating on LENZ Therapeutics Inc (LENZ): "continue to believe VIZZ holds blockbuster potential"
Mar 10, 2026 09:00AM Truelink Capital Closes Oversubscribed Fund II at $2.0 Billion Hard Cap
Mar 10, 2026 08:29AM William Blair Reiterates Outperform Rating on Standex International (SXI) following meetings with management
Mar 10, 2026 06:34AM William Blair Starts BridgeBio Pharma (BBIO) at Outperform
Mar 10, 2026 05:06AM Analysis-Gabon's uncertain push for IMF loan leads regional return to Fund
Mar 9, 2026 05:00PM MiniMed closes IPO raising $538 million at $20 per share
Mar 9, 2026 04:59PM MiniMed announces closing of Initial Public Offering
Mar 9, 2026 04:57PM William Blair Reiterates Outperform Rating on Nayax (NYAX) following earnings
Mar 9, 2026 04:19PM William Blair Reiterates Outperform Rating on StoneX Group Inc. (SNEX): "current price looks highly attractive"
Mar 9, 2026 04:01PM Dianthus Therapeutics announces $400 million public stock offering
Mar 9, 2026 04:01PM Xenon Pharmaceuticals announces $500 million public offering
Mar 9, 2026 04:01PM Xenon Pharmaceuticals Announces Proposed Public Offering
Mar 9, 2026 04:01PM Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
Mar 9, 2026 03:12PM William Blair Reiterates Outperform Rating on Kalaris (KLRS): "we see blockbuster potential for TH103 in nAMD"
Mar 9, 2026 02:44PM William Blair Reiterates Outperform Rating on Microsoft (MSFT) following product announcements
Mar 9, 2026 02:37PM William Blair Reiterates Market Perform Rating on ULTA Beauty (ULTA) ahead of earnings
Mar 9, 2026 02:30PM William Blair: 'We expect Microsoft to continue expanding its enterprise wallet share'
Mar 9, 2026 01:14PM William Blair Reiterates Outperform Rating on Crawford & Company (CRD-B): "Significant upside is possible"
Mar 9, 2026 11:52AM William Blair Reiterates Outperform Rating on Abbvie (ABBV): "competitive across the amylin class"
Mar 9, 2026 09:00AM William Blair Downgrades TalkSpace (TALK) to Market Perform
Mar 9, 2026 08:26AM William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE): "we see further room for upside"
View More Recent Stories View Older Stories